Table: begin end state 1 27 cytoplasmic 28 50 transmembrane 51 62 non-cytoplasmic 63 82 transmembrane 83 92 cytoplasmic 93 112 transmembrane 113 118 non-cytoplasmic 119 140 transmembrane 141 150 cytoplasmic 151 172 transmembrane 173 177 non-cytoplasmic 178 202 transmembrane 203 250 cytoplasmic 251 280 transmembrane 281 298 non-cytoplasmic 299 319 transmembrane 320 327 cytoplasmic 328 344 transmembrane 345 349 non-cytoplasmic 350 368 transmembrane 369 387 cytoplasmic 388 412 transmembrane 413 418 non-cytoplasmic 419 440 transmembrane 441 446 cytoplasmic
Input: >GFF1317 FitnessBrowser__WCS417:GFF1317 MNQPSVGTPLDVQSFINAQPLSRYQWRVVILCFLIVFLDGLDTAAMGFIAPALSQDWGID RASLGPVMSAALIGMVFGALGSGPLADRFGRKVVLVGAVLVFGAFSLASAYSSNVDQLLV LRFLTGLGLGAGMPNATTLLSEYTPERHKSLLVTSMFCGFNLGMAGGGFISAKLIPAFGW HALLLIGGILPLILVVVLMLWLPESARYLVVRNRGTDKVRKTLSPIDPVIVGQATSFSVP EQKTVKARNVFAVIFSGTYSAGTLLLWLTYFMGLVIVYLLTSWLPTLMRDSGASLEQAAF IGALFQFGGVLSAVGVGWAMDRFNPHKVIGSFYLLAGVFAYAVGQSLGNITLLATLVLIA GMCVNGAQSAMPSLAARFYPTQGRATGVSWMLGIGRFGAILGAWMGATLLGLGWNFEQVL TALVIPAALATAAVVIKGMVSHADAT
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server